Serving as the chairman of Cambridge Therapeutics in Alpine, NJ, John Klein has more than 20 years of experience in pharmaceutical manufacturing. In addition to leading Cambridge Therapeutics, John Klein functions as the chairman and CEO of Bilogix, an enterprise performance management (EPM) firm.

With a focus on helping business clients achieve maximum organizational efficiency and increase profits, Bilogix offers comprehensive analysis of operational data, as well as customized insights on improving business management. In today’s competitive business environment, EPM software and consulting services are considered necessary for organizations that want to boost their digital capabilities and remain profitable.

EPM analysis links financial data with performance metrics, which often reveals new strategies for generating revenue, as well as other steps for streamlining operations and cutting unnecessary costs. EPM solutions can also help managers and executives become more savvy as they use digital tools to monitor financial performance in real time and identify sales trends. Organizations of all types can benefit from an EPM solution in order to better understand their enterprise’s financial data and make more informed business decisions.